Skip to main content
Clinical Trials/IRCT20190904044697N8
IRCT20190904044697N8
Recruiting
N/A

A clinical trial to evaluate using electroporation system for treatment purposes and drug delivery to the tumor

Iran Nano Fund0 sites70 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran Nano Fund
Enrollment
70
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Iran Nano Fund

Eligibility Criteria

Inclusion Criteria

  • Cancer patients who have different types of cancer with solid tumors.
  • cancer stage IA, IB, IIA, IIB, IIIA, IIIB, IV
  • (Karnofsky Score \= ??)
  • Patients with different types of benign and malignant tumors

Exclusion Criteria

  • Coagulation disorder (INR more than 1\.5 times control)
  • Platelets less than 100,000
  • Anemia (hemoglobin less than 10\)
  • Serious acute infection
  • Having an implanted pacemaker, defibrillator or deep brain stimulator or cardiac arrhythmias.

Outcomes

Primary Outcomes

Not specified

Similar Trials